Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Rogier Hintzen, Alexey Boyко et al.|The Lancet Neurology|2019Cited by 185
Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndromeClara Matute‐Blanch, Manuel Comabella, С. В. Лапин et al.|Brain|2018Cited by 161
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosisSunny Malhotra, Manuel Comabella, Ramil Nurtdinov et al.|Brain|2015Cited by 110